Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterials - PALUMED

Drug Profile

Research programme: antibacterials - PALUMED

Alternative Names: Antibioquines; Hybrid antibacterials - PALUMED; PA 1046; PA 1409; Vancomyquine; Vancomyquine PA1409 (anti-MRSA drug)

Latest Information Update: 08 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PALUMED
  • Class Aminoquinolines; Cephalosporins; Glycopeptides
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Bacterial infections; Methicillin-resistant Staphylococcus aureus infections

Most Recent Events

  • 15 Sep 2009 Preclinical trials in Meticillin-resistant Staphylococcus aureus infections in France (unspecified route)
  • 15 Sep 2009 Antimicrobial, pharmacokinetic & pharmacodynamic data from preclinical trials of PA 1409 in Bacterial infections (including MRSA) presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2009) ,,
  • 21 Feb 2007 Preclinical trials in Bacterial infections in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top